Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice

Sanfilippo syndrome Type-B, also known as mucopolysaccharidosis IIIB (MPS IIIB), accounts for approximately one-third of all Sanfilippo syndrome patients and is characterized by a similar natural history as Type-A. Patients suffer from developmental regression, bone malformation, organomegaly, GI di...

Full description

Bibliographic Details
Main Authors: Frederick James Ashby, Evelyn J. Castillo, Yan Ludwig, Natalia K. Andraka, Cong Chen, Julia C. Jamieson, Nadia Kabbej, John D. Sommerville, Jose I. Aguirre, Coy D. Heldermon
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/18/13988
_version_ 1797579663756754944
author Frederick James Ashby
Evelyn J. Castillo
Yan Ludwig
Natalia K. Andraka
Cong Chen
Julia C. Jamieson
Nadia Kabbej
John D. Sommerville
Jose I. Aguirre
Coy D. Heldermon
author_facet Frederick James Ashby
Evelyn J. Castillo
Yan Ludwig
Natalia K. Andraka
Cong Chen
Julia C. Jamieson
Nadia Kabbej
John D. Sommerville
Jose I. Aguirre
Coy D. Heldermon
author_sort Frederick James Ashby
collection DOAJ
description Sanfilippo syndrome Type-B, also known as mucopolysaccharidosis IIIB (MPS IIIB), accounts for approximately one-third of all Sanfilippo syndrome patients and is characterized by a similar natural history as Type-A. Patients suffer from developmental regression, bone malformation, organomegaly, GI distress, and profound neurological deficits. Despite human trials of enzyme replacement therapy (ERT) (SBC-103, AX250) in MPS IIIB, there is currently no FDA approved treatment and a few palliative options. The major concerns of ERT and gene therapy for the treatment of bone malformation are the inadequate biodistribution of the missing enzyme, N-acetyl-α-glucosaminidase (NAGLU), and that the skeleton is a poorly hit target tissue in ERT and gene therapy. Each of the four known human types of MPS III (A, B, C, and D) is usually regarded as having mild bone manifestations, yet it remains poorly characterized. This study aimed to determine bone mineral content (BMC), volumetric bone mineral density (vBMD), and biomechanical properties in femurs MPS IIIB C57BL/6 mice compared to phenotypic control C57BL/6 mice. Significant differences were observed in MPS IIIB mice within various cortical and cancellous bone parameters for both males and females (<i>p</i> < 0.05). Here, we establish some osteogenic manifestations of MPS IIIB within the mouse model by radiographic and biomechanical tests, which are also differentially affected by age and sex. This suggests that some skeletal features of the MPS IIIB mouse model may be used as biomarkers of peripheral disease correction for preclinical treatment of MPS IIIB.
first_indexed 2024-03-10T22:40:23Z
format Article
id doaj.art-824cbd65d6b748d0b4b34c94206bdd1c
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T22:40:23Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-824cbd65d6b748d0b4b34c94206bdd1c2023-11-19T11:06:12ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-09-0124181398810.3390/ijms241813988Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B MiceFrederick James Ashby0Evelyn J. Castillo1Yan Ludwig2Natalia K. Andraka3Cong Chen4Julia C. Jamieson5Nadia Kabbej6John D. Sommerville7Jose I. Aguirre8Coy D. Heldermon9Department of Medicine, University of Florida, Gainesville, FL 32611, USADepartment of Physiological Sciences, University of Florida, Gainesville, FL 32611, USADepartment of Medicine, University of Florida, Gainesville, FL 32611, USADepartment of Medicine, University of Florida, Gainesville, FL 32611, USADepartment of Orthopaedic Surgery & Sports Medicine, University of Florida, Gainesville, FL 32611, USADepartment of Medicine, University of Florida, Gainesville, FL 32611, USADepartment of Medicine, University of Florida, Gainesville, FL 32611, USADepartment of Medicine, University of Florida, Gainesville, FL 32611, USADepartment of Physiological Sciences, University of Florida, Gainesville, FL 32611, USADepartment of Medicine, University of Florida, Gainesville, FL 32611, USASanfilippo syndrome Type-B, also known as mucopolysaccharidosis IIIB (MPS IIIB), accounts for approximately one-third of all Sanfilippo syndrome patients and is characterized by a similar natural history as Type-A. Patients suffer from developmental regression, bone malformation, organomegaly, GI distress, and profound neurological deficits. Despite human trials of enzyme replacement therapy (ERT) (SBC-103, AX250) in MPS IIIB, there is currently no FDA approved treatment and a few palliative options. The major concerns of ERT and gene therapy for the treatment of bone malformation are the inadequate biodistribution of the missing enzyme, N-acetyl-α-glucosaminidase (NAGLU), and that the skeleton is a poorly hit target tissue in ERT and gene therapy. Each of the four known human types of MPS III (A, B, C, and D) is usually regarded as having mild bone manifestations, yet it remains poorly characterized. This study aimed to determine bone mineral content (BMC), volumetric bone mineral density (vBMD), and biomechanical properties in femurs MPS IIIB C57BL/6 mice compared to phenotypic control C57BL/6 mice. Significant differences were observed in MPS IIIB mice within various cortical and cancellous bone parameters for both males and females (<i>p</i> < 0.05). Here, we establish some osteogenic manifestations of MPS IIIB within the mouse model by radiographic and biomechanical tests, which are also differentially affected by age and sex. This suggests that some skeletal features of the MPS IIIB mouse model may be used as biomarkers of peripheral disease correction for preclinical treatment of MPS IIIB.https://www.mdpi.com/1422-0067/24/18/13988Sanfilippo syndromeMPS IIIBlysosomal storage diseasebonemodel
spellingShingle Frederick James Ashby
Evelyn J. Castillo
Yan Ludwig
Natalia K. Andraka
Cong Chen
Julia C. Jamieson
Nadia Kabbej
John D. Sommerville
Jose I. Aguirre
Coy D. Heldermon
Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice
International Journal of Molecular Sciences
Sanfilippo syndrome
MPS IIIB
lysosomal storage disease
bone
model
title Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice
title_full Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice
title_fullStr Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice
title_full_unstemmed Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice
title_short Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice
title_sort femoral structure and biomechanical characteristics in sanfilippo syndrome type b mice
topic Sanfilippo syndrome
MPS IIIB
lysosomal storage disease
bone
model
url https://www.mdpi.com/1422-0067/24/18/13988
work_keys_str_mv AT frederickjamesashby femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice
AT evelynjcastillo femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice
AT yanludwig femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice
AT nataliakandraka femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice
AT congchen femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice
AT juliacjamieson femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice
AT nadiakabbej femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice
AT johndsommerville femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice
AT joseiaguirre femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice
AT coydheldermon femoralstructureandbiomechanicalcharacteristicsinsanfilipposyndrometypebmice